Skip to main content
Fig. 2 | Journal of Ovarian Research

Fig. 2

From: Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse

Fig. 2

Progression-free survival analysis of patients. A PFS of PARPi monotherapy and platinum-based chemotherapy in patients with secondary platinum-sensitive relapse was similar. B The benifit of platinum-based chemotherapy after PARPi resistance was positively correlated with the duration of PARPi administration

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us